Pacific Biosciences of California (PACB)
(Delayed Data from NSDQ)
$1.55 USD
-0.01 (-0.32%)
Updated Apr 22, 2024 11:56 AM ET
After-Market: $1.53 -0.02 (-0.97%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth A Momentum D VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC5/9/24 |
---|---|
Current Quarter | -0.26 |
EPS Last Quarter | -0.27 |
Last EPS Surprise | 12.90% |
ABR | 1.86 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.01 |
Next Year | -0.85 |
EPS (TTM) | -1.11 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | 56.81M | NA | 333.46M |
# of Estimates | NA | 3 | NA | 4 |
High Estimate | NA | 57.17M | NA | 394.56M |
Low Estimate | NA | 56.36M | NA | 229.20M |
Year ago Sales | 38.90M | 47.57M | 200.52M | NA |
Year over Year Growth Est. | NA | 19.42% | NA | NA |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.26 | -0.25 | -1.01 | -0.85 |
# of Estimates | 3 | 3 | 5 | 4 |
Most Recent Consensus | NA | NA | -1.05 | NA |
High Estimate | -0.24 | -0.24 | -0.93 | -0.80 |
Low Estimate | -0.27 | -0.25 | -1.05 | -0.91 |
Year ago EPS | -0.31 | -0.26 | -1.11 | -1.01 |
Year over Year Growth Est. | 16.13% | 3.85% | 9.01% | 15.64% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.26 | -0.25 | -1.01 | -0.85 |
7 Days Ago | -0.26 | -0.25 | -1.01 | -0.85 |
30 Days Ago | -0.26 | -0.25 | -1.01 | -0.85 |
60 Days Ago | -0.26 | -0.25 | -1.01 | -0.85 |
90 Days Ago | -0.28 | -0.26 | -1.01 | -0.87 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.26 | -0.25 | -1.01 | -0.85 |
Zacks Consensus Estimate | -0.26 | -0.25 | -1.01 | -0.85 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.27 | -0.27 | -0.26 | -0.31 | NA |
Estimate | -0.31 | -0.30 | -0.34 | -0.33 | NA |
Difference | 0.04 | 0.03 | 0.08 | 0.02 | 0.04 |
Surprise | 12.90% | 10.00% | 23.53% | 6.06% | 13.12% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more